Research Topics
| G C WishartSummaryAffiliation: Addenbrooke's Hospital Country: UK Publications
| Collaborators
|
Detail Information
Publications
PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancerGordon C Wishart
Cambridge Breast Unit, Addenbrooke s Hospital, Hills Road, Cambridge, CB2 2QQ, UK
Breast Cancer Res 12:R1. 2010..The aim of this study was to develop and validate a prognostication model to predict overall and breast cancer specific survival for women treated for early breast cancer in the UK...
Hormone receptor status in primary breast cancer--time for a consensus?G C Wishart
Cambridge Breast Unit, Box 97, Addenbrooke s Hospital, Cambridge, UK
Eur J Cancer 38:1201-3. 2002..It is essential that a consensus be reached regarding the choice of technique, as well as the threshold for positivity...
Measuring performance in clinical breast examinationG C Wishart
Cambridge Breast Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
Br J Surg 97:1246-52. 2010..The aim of this retrospective audit was to compare the performance and accuracy of CBE to identify key indicators that could be used to monitor performance prospectively...
The accuracy of digital infrared imaging for breast cancer detection in women undergoing breast biopsyG C Wishart
Cambridge Breast Unit, Addenbrooke s Hospital, Hills Road, Cambridge, CB2 2QQ, UK
Eur J Surg Oncol 36:535-40. 2010..Recent improvements in digital infrared breast imaging suggest there may be a role for this technology and we have studied its performance in 100 women prior to breast needle core biopsy (CB)...
Screen-detected vs symptomatic breast cancer: is improved survival due to stage migration alone?G C Wishart
Cambridge Breast Unit, Box 97, Addenbrooke s Hospital, Hills Road, Cambridge CB2 2QQ, UK
Br J Cancer 98:1741-4. 2008..Current prognostication tools may, therefore, overestimate the benefit of systemic treatments in screen-detected cancers and lead to overtreatment of these patients...
Use of ultrasound-guided axillary node core biopsy in staging of early breast cancerP D Britton
Department of Radiology Cambridge Breast Unit, Addenbrooke s Hospital, Cambridge, UK
Eur Radiol 19:561-9. 2009..CB of axillary lymph nodes can diagnose a substantial number of patients with lymph node metastases, allowing these patients to proceed directly to ALND, avoiding unnecessary SLN biopsy...
Treatment and survival in breast cancer in the Eastern Region of EnglandG C Wishart
Cambridge Breast Unit, Addenbrooke s Hospital, Cambridge, London, UK
Ann Oncol 21:291-6. 2010..The reasons for variation in survival in breast cancer are multifactorial...
A population-based validation of the prognostic model PREDICT for early breast cancerG C Wishart
Cambridge Breast Unit, Addenbrooke s Hospital, Hills Road, Cambridge, CB2 2QQ, UK
Eur J Surg Oncol 37:411-7. 2011..The aim of this study was to compare the 10-year survival estimates from Predict with observed 10-year outcome from a British Columbia dataset and to compare the estimates with those generated by Adjuvant! (www.adjuvantonline.com)...
Measuring the accuracy of diagnostic imaging in symptomatic breast patients: team and individual performanceP Britton
Department of Radiology, Cambridge Breast Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
Br J Radiol 85:415-22. 2012..To improve radiology reporting performance, the sensitivity of cancer reporting should be closely monitored; there should be regular feedback from needle biopsy results and discussion of reporting classification with colleagues...
Ultrasound guided percutaneous axillary lymph node core biopsy: how often is the sentinel lymph node being biopsied?P D Britton
Department of Radiology, Addenbrooke s Hospital, Cambridge Breast Unit, Cambridge, UK
Breast 18:13-6. 2009..This study suggests that both better methods of identifying the sentinel lymph node and more adequate sampling are required...
One-stop diagnostic breast clinics: how often are breast cancers missed?P Britton
Department of Radiology, Cambridge Breast Unit, Box 97, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 2QQ, UK
Br J Cancer 100:1873-8. 2009..e., a 'missed' cancer) occurred in only nine patients (31%). The overall diagnostic accuracy of 'triple' assessment is 99.6% and the 'missed' cancer rate is 1.7 per 1000 women discharged...
Radiological staging in breast cancer: which asymptomatic patients to image and howT Barrett
Department of Radiology, Box 219, Addenbrooke s Hospital, Cambridge University Teaching Hospitals NHS Foundation Trust, Hills Road, Cambridge CB2 0QQ, UK
Br J Cancer 101:1522-8. 2009..Approximately 4% of patients diagnosed with early breast cancer have occult metastases at presentation. Current national and international guidelines lack consensus on whom to image and how...
Molecular characteristics of screen-detected vs symptomatic breast cancers and their impact on survivalS J Dawson
Department of Oncology, University of Cambridge, Cambridge, UK
Br J Cancer 101:1338-44. 2009..This study compares the molecular characteristics of screen-detected with symptomatic breast cancers to identify if differences in tumour biology may explain some of the survival benefit conferred by screen detection...
Patient and tumour characteristics, management, and age-specific survival in women with breast cancer in the East of EnglandA M G Ali
Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, CB1 8RN, UK
Br J Cancer 104:564-70. 2011..We examined the influence of patient and tumour characteristics, and treatment on BCRS to see whether these could explain the age-specific effect...
P-glycoprotein expression is associated with sestamibi washout in primary hyperparathyroidismY Gupta
Department of Endocrine Surgery, Addenbrooke s Hospital, Cambridge, UK
Br J Surg 94:1491-5. 2007..This study examined the relationship between sestamibi accumulation and multidrug resistance (MDR)-related P-glycoprotein (P-gp) expression in a large series of surgically excised parathyroid tumours...
Patient-led breast cancer follow upD Chapman
Cambridge Breast Unit, Addenbrooke s Hospital, Cambridge, Cambridgeshire, UK
Breast 18:100-2. 2009..Only 10 of 277 GP respondents (3.6%) referred a patient on PLFU back to the breast unit during the study period. PLFU has been well received by patients following breast cancer treatment with little increase in GP workload...
The Cambridge Breast Intensity-modulated Radiotherapy Trial: Patient- and Treatment-related Factors that Influence Late ToxicityG C Barnett
University of Cambridge Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
Clin Oncol (R Coll Radiol) 23:662-73. 2011..The aim of this study was to elucidate the relative importance of such factors in the development of late toxicity after breast-conserving surgery and adjuvant breast radiotherapy...
Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy?R M L Warren
Department of Radiology, Cambridge Breast Unit, Addenbrooke s Hospital, Cambridge CB2 2QQ, UK
Br J Cancer 90:1349-60. 2004..CE MRI persistently underestimated minimal residual disease. In conclusion, CE MRI of breast cancer proved more reliable for predicting histopathological response to neoadjuvant chemotherapy than conventional assessment methods...
Technical note. Lateral approach to parathyroid adenoma excisionS K Thomas
Department of General Surgery, Addenbrooke's Hospital, Cambridge, UK
Ann R Coll Surg Engl 86:474-5. 2004
Minimally invasive parathyroid surgery for recurrent intrathyroid multiple endocrine neoplasia (MEN)M Turner
Department of General Surgery, Addenbrooke's Hospital, Cambridge, UK
Ann R Coll Surg Engl 86:W52-3. 2004..A case of recurrent multiple endocrine neoplasia-related hyperparathyroidism treated by minimally invasive parathyroid surgery is discussed...
Titanium clip placement to allow accurate tumour bed localisation following breast conserving surgery: audit on behalf of the IMPORT Trial Management GroupC E Coles
Cambridge Breast Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
Eur J Surg Oncol 35:578-82. 2009..We audited the value of titanium clips for TB localisation following breast conserving surgery (BCS) in breast radiotherapy (RT) planning...
Focused parathyroid surgery with intraoperative parathyroid hormone measurement as a day-case procedureE M Gurnell
Department of Medicine, Addenbrooke's Hospital, Cambridge, UK
Br J Surg 91:78-82. 2004..CONCLUSION: After accurate preoperative localization of uniglandular disease, patients with primary hyperparathyroidism may be managed successfully and safely by focused parathyroidectomy with IOPTH measurement as a day-case procedure...
Lobular carcinoma in situ on core biopsy-what is the clinical significance?P Britton
Department of Radiology, Addenbrooke's Hospital, Cambridge, UK
Clin Radiol 56:216-20. 2001..Decisions on management should be undertaken in a multidisciplinary setting taking into account clinical and imaging findings...
Tamoxifen: the drug that came in from the coldL Hughes-Davies
Cambridge Breast Unit, Addenbrooke s Hospital, Hills Road, Cambridge, UK
Br J Cancer 101:875-8. 2009....
Sentinel lymph node biopsy in breast cancer--is lymphoscintigraphy really necessary?S S Upponi
Cambridge Breast Unit, Addenbrooke's Hospital, UK
Eur J Surg Oncol 28:479-80. 2002..This study questions the contribution of lymphoscintigraphy in axillary sentinel node biopsy, however its value may lie in the detection of extra-axillary nodes...
Trends in surgical techniquesS K Thomas
Department of General Surgery, Addenbrooke's Hospital, Hills Road, Cambridge CB2 2QQ, UK
Nucl Med Commun 24:115-9. 2003..This review provides an overview of the different surgical approaches currently used for the management of primary hyperparathyroidism and discusses the indications, advantages and disadvantages of each technique...
Clip placement during axillary clearance: defining the radiotherapy targetG Horan
Clin Oncol (R Coll Radiol) 18:721-2. 2006
Advances in axillary surgery for breast cancer--time for a tailored approachA D Purushotham
Eur J Surg Oncol 31:929-31. 2005
